Rainer Christine

Rainer Christine is a partner at Earlybird, a venture capital firm. Rainer has also served as the CEO and co-founder of amaxa AG/amaxa Inc., a company that developed and commercialized Nucleofector technology for the transfection of primary cells and hard-to-transfect cell lines. Under their leadership, the company grew from two founders to 160 employees and generated EUR 20 million in annual sales before being acquired by Lonza in 2008.

Rainer Christine attended Universität zu Köln and University of Sussex.

They are on a team with Alexander Muller - Partner, Emanuel Wollersheim - VP Finance, and Lionel Carnot - Partner. Rainer Christine reports to Roland Manger, Co-Founder & Partner.